New MRD Assessment Data Using clonoSEQ® To Be Presented at 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress

Read More

Unveiling the Brilliance of the Adaptive Immune System

Adaptive launches its first research product, immunoSEQ. Scientists worldwide now have this sophisticated tool to profile and monitor the adaptive immune response, to propel their research in many diseases, and to understand the immune response to therapies.

“We have delivered the Hubble Telescope as compared to a pair of binoculars to look at the adaptive immune system.”
Chad Robins, Chief Executive Officer, Co-founder, Chairman of the Board